NCT00309309View on ClinicalTrials.gov

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

July 31, 2007

Conditions
Kidney Transplant
Interventions
DRUG

Rosiglitazone

Trial Locations (1)

24020

Clinical Research Center for Rare Diseases, Ranica

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00309309 - Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant | Biotech Hunter | Biotech Hunter